Kerui Xu

Kerui Xu

Auto-generated profile, based on publicly available information

Kerui Xu

University of Illinois Urbana-Champaign

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Forensic Science International: Genetics
Verified
Journal Article
Closed access
CCCharles Clark
Charles Clark
KXKerui Xu
Kerui Xu
OSOrion Scott
Orion Scott
JHJeffrey Hickey
Jeffrey Hickey
ATAn-Chi Tsuei
An-Chi Tsuei
James P. LandersJames P. Landers
James P. Landers

30 November 2021 in Analytical Chemistry
Verified
Journal Article
Closed access
HJHenry D. Jetmore
Henry D. Jetmore
CMConrad B. Milton
Conrad B. Milton
EAEdappalil Satheesan Anupriya
Edappalil Satheesan Anupriya
RCRan Chen
Ran Chen
KXKerui Xu
Kerui Xu
MSMei Shen
Mei Shen

1 October 2020 in Electrochimica Acta
Verified
Journal Article
Closed access
RCRan Chen
Ran Chen
KXKerui Xu
Kerui Xu
MSMei Shen
Mei Shen

10 September 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
MRMonika Rana
Monika Rana
KTKarna Terpstra
Karna Terpstra
CGCitlali Gutierrez
Citlali Gutierrez
KXKerui Xu
Kerui Xu
HAHemant Arya
Hemant Arya
ASAnuj Kumar Sharma
Anuj Kumar Sharma
Inhibition of amyloid β (Aβ) aggregation and cholinesterase activity are two major therapeutic targets for Alzheimer’s disease (AD). Multifunctional Molecules (MFMs) specifically designed to address other contributing factors, such as metal ion induced abnormalities, oxidative stress, toxic A aggregates etc. are very much required. Several multifunctional molecules have been developed using different molecular scaffolds. Reported herein is a new series of four MFMs based on ThT, Azo-stilbene and metal ion chelating pockets. The synthesis, characterization, and metal chelation ability for [Cu(II) and Zn(II)] are presented herein. Furthermore, we explored their multifunctionality w.r.t. to their (i) recognition of Aβ aggregates and monomeric form, (ii) utility in modulating the aggregation pathways of both metal-free and metal-bound amyloid-β, (iii) ex-vivo staining of amyloid plaques in 5xFAD mice brain sections, (iv) ability to scavenge free radicals and (v) ability to inhibit cholinesterase activity. Molecular docking studies were also performed with Aβ peptides and acetylcholinesterase enzyme to understand the observed inhibitory effect on activity. Overall, the studies presented here establish the multifunctional nature of these molecules and qualify them as promising candidates for furthermore investigation in the quest for finding Alzheimer’s disease treatment.